Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome

被引:34
|
作者
Ikeda, M
Ito, S
Hataya, H
Honda, M
Anbo, K
机构
[1] Tokyo Metropolitan Kiyose Childrens Hosp, Div Pediat Nephrol, Tokyo 2048567, Japan
[2] Nippon Med Coll, Dept Pediat, Tokyo 113, Japan
关键词
leukoencephalopathy; nephrotic syndrome; hypertension; methylprednisolone; convulsion; visual disturbance; magnetic resonance imaging (MRI); computed tomography (CT);
D O I
10.1053/ajkd.2001.22867
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 9-year-old boy with nephrotic syndrome was transferred to our hospital because of acute renal failure and disturbance of consciousness after high-dose methylprednisolone therapy. He developed severe headache, visual disturbance, and generalized seizures. Brain computed tomography (CT) scan revealed multiple, bilateral, low-density areas In the parieto-occipital lobes. Magnetic resonance Imaging (MRI) disclosed a high signal intensity area on T2-weighted Images and a low signal Intensity area on TI-weighted images in the same lesion. Follow-up brain CT scan and MRI, 2 weeks after the first studies, showed complete resolution of the abnormal lesions, which suggested the diagnosis of reversible posterior leukoencephalopathy syndrome (RPLS). Hypertension and high-dose methylprednisolone administration to the patient In the nephrotic state may be causes of this uncommon syndrome in this case. This Is the first report of RPLS In nephrotic syndrome with hypertension not associated with cyclosporine administration. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Reversible posterior leukoencephalopathy associated with minimal change nephrotic syndrome
    Looi, Jen Li
    Christiansen, Jonathan
    NEW ZEALAND MEDICAL JOURNAL, 2006, 119 (1243) : 72 - 75
  • [2] Buerger's disease in a patient with minimal-change nephrotic syndrome
    Matsuo, S
    Nakamoto, M
    Nishihara, G
    Yasunaga, C
    Yanagida, T
    Matsuo, K
    Sakemi, T
    NEPHRON, 2001, 89 (03): : 357 - 358
  • [3] SALSALATE AND MINIMAL-CHANGE NEPHROTIC SYNDROME
    VALLES, M
    TOVAR, JL
    ANNALS OF INTERNAL MEDICINE, 1987, 107 (01) : 116 - 116
  • [4] STEROIDS IN MINIMAL-CHANGE NEPHROTIC SYNDROME
    HOPPER, J
    LEE, JC
    ROSENAU, W
    LANCET, 1972, 2 (7769): : 187 - &
  • [5] CYCLOPHOSPHAMIDE IN MINIMAL-CHANGE NEPHROTIC SYNDROME
    RIZVI, SNA
    VAISHNAVA, H
    LANCET, 1972, 2 (7770): : 229 - +
  • [6] CYCLOPHOSPHAMIDE IN MINIMAL-CHANGE NEPHROTIC SYNDROME
    ULDALL, PR
    TOMLINSON, BE
    KERR, DNS
    MORLEY, AR
    FEEST, TG
    LANCET, 1972, 2 (7776): : 537 - +
  • [7] IMMUNOHISTOLOGIC FEATURES OF MINIMAL-CHANGE NEPHROTIC SYNDROME
    RAO, PD
    ZIMMERMAN, SW
    BURKHOLDER, PM
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1977, 101 (07) : 345 - 349
  • [8] SERUM IMMUNOGLOBULINS IN NEPHROTIC SYNDROME - POSSIBLE CAUSE OF MINIMAL-CHANGE NEPHROTIC SYNDROME
    GIANGIACOMO, J
    CLEARY, TG
    COLE, BR
    HOFFSTEN, P
    ROBSON, AM
    NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (01): : 8 - 12
  • [9] CYCLOPHOSPHAMIDE THERAPY IN ADULTS WITH MINIMAL-CHANGE NEPHROTIC SYNDROME
    ULDALL, PR
    TOMLINSON, BE
    FEEST, TG
    KERR, DNS
    MORLEY, AR
    LANCET, 1972, 1 (7763): : 1250 - +
  • [10] LYMPHOCYTE-TRANSFORMATION IN MINIMAL-CHANGE NEPHROTIC SYNDROME
    SZEWCZYK, Z
    KLINGER, M
    MAIGA, K
    LANCET, 1977, 1 (8008): : 433 - 434